Tag: interstitial lung disease (ILD)

650×450-Scleroderma-NSIP

Trial Results Offer New Hope for Scleroderma Patients

Nintedanib significantly reduces loss of lung function

18-PUL-5877
December 21, 2018/Pulmonary/Clinical Trial

Improving Treatment Outcomes for Patients with Rheumatic Lung Disease

Three clinical trials testing old and new drugs

18-PUL-444-sclerodermaNSIP-650×450
December 13, 2018/Pulmonary/News & Insight

Exploring Novel Treatment for Scleroderma-Associated Interstitial Lung Disease

Largest trial to date is studying use of nintedanib

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

18-PUL-4979-Highland-Hero-Image-650x450pxl
December 5, 2018/Pulmonary/News & Insight

Exploring Novel Treatment for CTD-Associated Pulmonary Hypertension

Multicenter trial studies use of bardoxolone

18-PUL-4645-Tolle-Hero-Image-650x450pxl[5]

How to Treat Idiopathic Pulmonary Fibrosis

An overview of available treatment modalities

18-PUL-4540-Culver-Hero-Image-650x450pxl

Cleveland Clinic Joins Pulmonary Fibrosis Foundation’s Care Center Network

In recognition of Respiratory Institute’s national expertise

BackPage 2 of 3Next

Advertisement

Ad